Business Standard

Monday, December 23, 2024 | 04:23 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Advisory board urges ban on codeine cough drugs, regulator to take call

Codeine formulations constitute 8% of cough and cold market; pharma industry asks govt not to ban a 'safe' medicine for abuse by some

cough syrup, medicine, cold
Premium

File photo of cough syrup. Photo: Shutterstock

Sohini Das Mumbai
The Drugs Technical Advisory Board (DTAB) has recommended a ban on codeine-based formulations, and now the country’s drug regulator would take a final call on the matter, multiple sources in the know said. If implemented, the ban on codeine preparations, which contribute about 8 per cent of the cough and cold market today, would lead to an impact of around Rs 43 crore.

Codeine-based formulations are under the scanner for misuse as a narcotic product. Several smuggling rackets have been busted and codeine formulations (cough syrups mostly) seized. Many people misuse this medication (which is an opioid product) to get

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in